Novartis AG develops, manufactures, and markets healthcare products internationally. It offers prescription medicines for patients and physicians. Focus areas include cardiovascular, renal, immunology, neuroscience, oncology, ophthalmology, and hematology. Novartis has partnerships with Alnylam Pharmaceuticals and Dawn Health to develop and commercialize therapies.
| Indicator | Value |
|---|---|
| PER | 20.9 |
| EV/EBITDA | 12.8 |
| Price/Free Cash Flow' | 18.0 |
| ROIC | 24.0% |
| Net Debt/EBITDA | 0.9 |